Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma

BMC Pulmonary Medicine

Volumn 11, Issue , 2011, Pages

  Ishikawa, Nobuhisa ^a,b   Mazur, Witold ^a   Toljamo, Tuula ^c   Vuopala, Katri ^c   Rönty, Mikko ^a   Horimasu, Yasushi ^b   Kohno, Nobuoki ^b   Kinnula, Vuokko L ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HIROSHIMA UNIVERSITY   (Japan)

^c LAPLAND CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLYCOPROTEIN; KL 6 PROTEIN; PREDNISOLONE; UNCLASSIFIED DRUG; MUC1 PROTEIN, HUMAN; MUCIN 1;

ADULT; AGED; AGING; ARTICLE; BLOOD SAMPLING; BRONCHIOLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIGITAL IMAGING; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PLASMA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK FACTOR; SMOKING HABIT; SPUTUM; SPUTUM LEVEL; SPUTUM SMEAR; SUPERNATANT; BRONCHUS; CASE CONTROL STUDY; EPITHELIUM; FINLAND; LUNG ALVEOLUS; METABOLISM; MIDDLE AGED; PATHOLOGY; SMOKING;

ADULT; AGED; AGING; BRONCHI; CASE-CONTROL STUDIES; EPITHELIUM; FEMALE; FINLAND; HUMANS; LUNG; MALE; MIDDLE AGED; MUCIN-1; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM;

EID: 79955752604     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-11-22     Document Type: Article

References (40)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997, 349:1436-1442. 10.1016/S0140-6736(96)07495-8, 9164317.
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, . Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555. 10.1164/rccm.200703-456SO, 17507545, Global Initiative for Chronic Obstructive Lung Disease.
3. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006, 28:523-532. 10.1183/09031936.06.00124605, 16611654.
4. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008, 63:402-407. 10.1136/thx.2007.085456, 18234906.
5. Toljamo T, Kaukonen M, Nieminen P, Kinnula VL. Early detection of COPD combined with individualized lycopepti for smoking cessation: a two-year prospective study. Scand J Prim Health Care 2010, 28:41-46. 10.3109/02813431003630105, 20331388.
6. Rytilä P, Rehn T, Ilumets H, Rouhos A, Sovijärvi A, Myllärniemi M, Kinnula VL. Increased oxidative stress in asymptomatic current chronic smokers and GOLD Stage 0 COPD. Respir Res 2006, 7:69. 10.1186/1465-9921-7-69, 1524947, 16646959.
7. Kinnula VL, Ilumets H, Myllärniemi M, Sovijärvi A, Rytilä P. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J 2007, 29:51-55.
8. Mazur W, Stark H, Sovijärvi A, Myllärniemi M, Kinnula VL. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers. Respiration 2009, 78:209-216. 10.1159/000206010, 19252398.
9. Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page CP, Postma D, Saetta M. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174:6-14. 10.1164/rccm.200510-1659PP, 16556692.
10. Louhelainen N, Myllärniemi M, Rahman I, Kinnula VL. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. Int J Chron Obstruct Pulmon Dis 2008, 3:585-603. 2650600, 19281076.
11. Kinnula VL, Crapo JD, Raivio KO. Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 1995, 73:3-19.
12. Rahman I. Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2008, 2:351-374. 10.1177/1753465808098224, 2744584, 19124382.
13. Pettersen CA, Adler KB. Airways inflammation and COPD: epithelial-neutrophil interactions. Chest 2002, 121(5 Suppl):142S-150S.
14. Kinnula VL. Production and degradation of oxygen metabolites during inflammatory states in the human lung. Curr Drug Targets Inflamm Allergy 2005, 4:465-470. 10.2174/1568010054526368, 16101523.
15. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988, 18:203-216.
16. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997, 17:501-507.
17. Ohyabu N, Hinou H, Matsushita T, Izumi R, Shimizu H, Kawamoto K, Numata Y, Togame H, Takemoto H, Kondo H, Nishimura S. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused lycopeptides library. J Am Chem Soc 2009, 131:17102-17109. 10.1021/ja903361f, 19899793.
18. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989, 96:68-73. 10.1378/chest.96.1.68, 2661160.
19. Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, Yokoyama A, Hamada H, Fujioka S, Hiwada K. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993, 148:637-642.
20. Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 2002, 165:378-381.
21. Hamari A, Toljamo T, Nieminen P, Kinnula VL. High frequency of chronic cough and sputum production with lowered exercise capacity in young smokers. Ann Med 2010, 42:512-520. 10.3109/07853890.2010.505933, 20662762.
22. National Institutes of Health, National Heart Lung and Blood Institute (2009) Global initiative for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. National Institutes of Health, National Heart Lung and Blood Institute (2009)., http://www.goldcopd.com
23. Viljanen AA, Halttunen PK, Kreus KE, Viljanen BC. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest Suppl 1982, 159:5-20.
24. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanović R, Maestrelli P, Sterk PJ. Sputum induction. Eur Respir J 2002, 37(Suppl):3s-8s.
25. Saraiva-Romanholo MB, Barnabé V, Carvalho AL, Martins MA, Saldiva PHN, Nunes Mdo P. Comparison of three methods for differential cell count in induced sputum. Chest 2003, 124:1060-1066. 10.1378/chest.124.3.1060, 12970038.
26. Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices sputum: effect of selection of sputum to minimize salivary contamination. Eur Respir J 1996, 9:1174-1180. 10.1183/09031936.96.09061174, 8804934.
27. Ohshimo S, Bonella F, Grammann N, Starke K, Cui A, Bauer PC, Teschler H, Kohno N, Guzman J, Costabel U. Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2009, 26:47-53.
28. Myllärniemi M, Vuorinen K, Pulkkinen V, Kankaanranta H, Aine T, Salmenkivi K, Keski-Oja J, Koli K, Kinnula V. Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. J Pathol 2008, 214:456-463.
29. Maestrelli P, Saetta M, Mapp CE, Fabbri LM. Remodeling in response to infection and injury: Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:S76-80.
30. Adler KB, Li Y. Airway epithelium and mucus: intracellular signaling pathways for gene expression and secretion. Am J Respir Cell Mol Biol 2001, 25:397-400.
31. Yin L, Li Y, Ren J, Kuwahara H, Kufe D. Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J Biol Chem 2003, 278:35458-35464. 10.1074/jbc.M301987200, 12826677.
32. Janssen R, Kruit A, Grutters JC, Ruven HJ, Gerritsen WB, van den Bosch JM. The mucin-1 568 adenosine to guanine polymorphism influences serum Krebs von den Lungen-6 levels. Am J Respir Cell Mol Biol 2006, 34:496-499. 10.1165/rcmb.2005-0151OC, 16357367.
33. Kobayashi H, Kanoh S, Motoyoshi K. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking. Biomarkers 2008, 13:385-392. 10.1080/13547500801903651, 18595202.
34. Morimoto K, Ishikawa R, Moriya A, Masunaga A, Kamiya H, Ando T, Ikushima S, Oritsu M. [Evaluation of KL-6 CLEIA reagent]. Nihon Kokyuki Gakkai Zasshi 2008, 46:859-863.
35. Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest 2009, 135:505-512. 10.1378/chest.08-0412, 19201713.
36. Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med 1997, 156:109-115.
37. Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE. Repeatability of inflammatory parameters in induced sputum of COPD patients. COPD 2007, 4:321-329. 10.1080/15412550701597720, 18027159.
38. Seyama K. State of alpha1-antitrypsin deficiency in Japan. Respirology 2001, 6(Suppl):S35-8.
39. Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010, 15:265-271. 10.1111/j.1440-1843.2009.01676.x, 20051048.
40. Laitinen T, Hodgson U, Kupiainen H, Tammilehto L, Haahtela T, Kilpeläinen M, Lindqvist A, Kinnula VL. Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease. COPD 2009, 6:256-262. 10.1080/15412550903051799, 19811384.